winged blood sampling set with protector
medical intertrade d.o.o. dr. franje tuđmana 3 10431 sveta nedelja -
spitztupfer- pointed swabs with x-ray
medical intertrade d.o.o. dr. franje tuđmana 3 10431 sveta nedelja -
2f cevox probe for use with cvc of various manuf., 0.67mm, usable lenght 48, total lenght 95cm
sonimed d.o.o. rozganska 8 10110 zagreb -
cryo tube with male thread, 5.0 ml
gorea plus d.o.o. svetonedeljska cesta 97 10431 kerestinec -
flow mir disposable turbine with mouthpiece / mir / jednokratne spirometrijske turbine s kartonskim usnikom za jednokranu upotre
elektroničar d.o.o. karlovačka cesta 26/a 10000 zagreb -
engage tr introducer (radial) 6f, 8.5 cm sheath with guidewire 0.025", wire/needle configuration:coated/cannula, hydrophili
sonimed d.o.o. rozganska 8 10110 zagreb -
oxygenator with integrated arterial filter and cardiotomy/venous reservoir with balance biosurface
medic d.o.o. trg dražena petrovića 3 10000 zagreb -
perivac periocardiocentesis kit with straight catheter
medical intertrade d.o.o. dr. franje tuđmana 3 10431 sveta nedelja -
tecartus
kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - limfom, mantel-stanica - antineoplastična sredstva - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).
oxbryta
pfizer europe ma eeig - voxelotor - anemia; anemia, hemolytic; anemia, sickle cell - other hematological agents - oxbryta is indicated for the treatment of haemolytic anaemia due to sickle cell disease (scd) in adults and paediatric patients 12 years of age and older as monotherapy or in combination with hydroxycarbamide.